BioCorRx (BICX) Capital Expenditures (2013 - 2021)

BioCorRx has disclosed Capital Expenditures across 7 years of filings, most recently posting $2017.0 for Q1 2021.

• Capital Expenditures for Q1 2021 came in at $2017.0, changed N/A year-over-year; the trailing twelve-month figure through Dec 2021 was $2017.0 (down 78.14% YoY), and the FY2021 annual result was $2017.0, down 78.14% from the prior year.
• Capital Expenditures came in at $2017.0 for Q1 2021 at BioCorRx, down from $2827.0 in the prior quarter.
• In the past five years, Capital Expenditures ranged from a high of $6400.0 in Q3 2020 to a low of -$59326.0 in Q3 2018.
• The 4-year median for Capital Expenditures is -$984.0 (2018), against an average of -$19073.2.
• Across the five-year window, Capital Expenditures plunged 5486.18% in 2019 and jumped 639900.0% in 2020, its largest moves.
• BioCorRx's Capital Expenditures stood at -$984.0 in 2018, then slumped by 5486.18% to -$54968.0 in 2019, then surged by 105.14% to $2827.0 in 2020, then declined by 28.65% to $2017.0 in 2021.
• The last three Capital Expenditures figures came in at $2017.0 (Q1 2021), $2827.0 (Q4 2020), and $6400.0 (Q3 2020), per Business Quant data.